Persistence and adherence with mirabegron versus antimuscarinics in overactive bladder: retrospective analysis of a UK General Practice Prescription Database

被引：0

作者：

Wagg, Adrian ^{[1
]}

Foley, Steve ^{[2
]}

Peters, John ^{[3
]}

Nazir, Jameel ^{[4
]}

Kool-Houweling, Leanne ^{[5
]}

Scrine, Ludmila ^{[6
]}

机构：

[1] Univ Alberta, Med, Edmonton, AB, Canada

[2] Royal Berkshire Hosp, Dept Urol, Reading, Berks, England

[3] Barts Hlth NHS Trust, Whipps Cross Hosp, Dept Urol, London, England

[4] Astellas Pharma Europe Ltd, Hlth Econ & Outcomes Res, Chertsey, England

[5] Quintiles Advisory Serv, Hoofddorp, Netherlands

[6] Astellas Pharma Europe, Chertsey, England

来源：

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2017年 / 211卷

关键词：

D O I：

10.1016/j.ejogrb.2017.01.028

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：199 / 200

页数：2

共 50 条

[21] Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real-world claims data analysis
Sussman, D.
Yehoshua, A.
Kowalski, J.
Lee, W.
Kish, J.
Chaudhari, S.
Murray, B.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (3-4)
[22] Italian real-life clinical setting: the persistence and adherence with mirabegron in women with overactive bladder
Illiano, Ester
Agro, Enrico Finazzi
Natale, Franca
Balsamo, Raffaele
Costantini, Elisabetta
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (06) : 1035 - 1042
[23] Italian real-life clinical setting: the persistence and adherence with mirabegron in women with overactive bladder
Ester Illiano
Enrico Finazzi Agrò
Franca Natale
Raffaele Balsamo
Elisabetta Costantini
International Urology and Nephrology, 2020, 52 : 1035 - 1042
[24] Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database
Mauseth, Siri A.
Skurtveit, Svetlana
Spigset, Olav
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (10) : 1208 - 1215
[25] RETROSPECTIVE ANALYSIS OF PERSISTENCE TO ANTI-OSTEOPOROSIS MEDICATIONS IN THE UK GENERAL PRACTICE RESEARCH DATABASE (GPRD)
Li, L.
Roddam, A.
Gitlin, M.
Taylor, A.
Shepherd, S.
Jick, S.
OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 252 - 253
[26] Real-World Adherence and Persistence of Vibegron in Patients With Overactive Bladder: A Retrospective Claims Analysis
Chastek, B.
Carrera, A.
Landis, C.
Snyder, D.
Abedinzadeh, L.
Bancroft, T.
Nesheim, J.
Staskin, D.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S199 - S199
[27] Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Chastek, Benjamin
Carrera, Adam
Landis, Christina
Snyder, Daniel
Abedinzadeh, Laleh
Bancroft, Tim
Nesheim, Jeffrey
Kennelly, Michael
Staskin, David
ADVANCES IN THERAPY, 2024, 41 (05) : 2086 - 2097
[28] Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
Benjamin Chastek
Adam Carrera
Christina Landis
Daniel Snyder
Laleh Abedinzadeh
Tim Bancroft
Jeffrey Nesheim
Michael Kennelly
David Staskin
Advances in Therapy, 2024, 41 : 2086 - 2097
[29] Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial
Kinjo, Manami
Sekiguchi, Yuki
Yoshimura, Yasukuni
Nutahara, Kikuo
LUTS-LOWER URINARY TRACT SYMPTOMS, 2018, 10 (02) : 148 - 152
[30] Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis
Tsubouchi, Kazuna
Maeda, Toshiki
Emoto, Taiki
Aoyagi, Chikao
Matsuoka, Wataru
Yamazaki, Fumihiro
Nakagawa, Chizuru
Fukuhara, Yuichiro
Tominaga, Kosuke
Gunge, Naotaka
Miyazaki, Takeshi
Okabe, Yu
Matsuzaki, Hiroshi
Nakamura, Nobuyuki
Arima, Hisatomi
Haga, Nobuhiro
NEUROUROLOGY AND URODYNAMICS, 2024, 43 (08) : 2207 - 2213

← 1 2 3 4 5 →